Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date of Report: June 20, 2023
Reporting Period: Event date June 20, 2023
The Company is an emerging growth company incorporated in Delaware, with principal executive offices in New York, NY. This filing reports a specific event regarding a government grant rather than a standard quarterly or annual financial period.
Key Financial Metrics
This filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics for a reporting period. The only financial data disclosed relates to a specific grant payment:
- Grant Payment Received: USD $1.43 million (Second progress payment).
- Total Grant Value: USD $4.7 million (Awarded in 2021).
- Total Funds Received to Date: USD $3.25 million.
Material Changes
The material change reported is the receipt of the second progress payment of USD $1.43 million under the Medical Products Priority Grant. This grant was awarded by the Australian Federal Government's Department of Industry, Science, Energy and Resources under the Modern Manufacturing Initiative. The funds are designated for the establishment of a state-of-the-art Australian medical device manufacturing facility.
Guidance, Outlook, and Risks
Conditions and Contingencies: The grant is subject to conditions and the achievement of certain deliverables. Failure to meet these conditions could impact future funding or require repayment, though specific penalties are not detailed in this filing.
Management Commentary: The filing references a press release (Exhibit 99.1) for full details and incorporates it by reference. No forward-looking guidance regarding revenue or earnings is provided in this specific 8-K text.
Investor Verification Checklist
- Verify the specific deliverables and conditions required to secure the remaining grant balance (USD $1.45 million).
- Review the attached Press Release (Exhibit 99.1) for details on the timeline for the Australian manufacturing facility.
- Confirm the Company's current cash position and how this grant payment impacts immediate liquidity, as this filing does not provide a balance sheet.
- Monitor future filings for updates on the status of the grant conditions and facility construction progress.